Delivery Order SPE2DR25D2206-SPE2DR26F9FK5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Exforge HCT 10-160-12.5 mg tablets (30-count) under a firm fixed price contract valued at $1,388.87. This is a non-set-aside delivery order with an ultimate completion date of November 5, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was...
- The Defense Logistics Agency awarded a delivery order valued at $1,014.88 to AmerisourceBergen Drug Corp for the supply of Exforge HCT 10-160-12.5 mg tablets (30-count package) on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action executed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Exforge 5-160 mg tablets (30-count units) with a ceiling value of $1,156.73. This firm fixed-price delivery order, which must be completed by December 8, 2025, carries no set-aside designation and was competitively awarded. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Exforge 10-320 mg tablets (30-count) with a ceiling value of $11,442.50. This firm fixed-price delivery order, without a set-aside designation, represents a competitively awarded contract executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order valued at $2,744.54 to AmerisourceBergen Drug Corp for the supply of Exforge HCT 10-160-12.5 mg tablets (30-count bottles) on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order was placed without set-aside designation and represents a single pharmaceutical supply transaction under the company's existing contract vehicle. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Exforge 5-320 mg tablets (30-count units) with a ceiling value of $11,807.90. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $22,617.45 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Exforge 10-320 mg tablets (30-count). This is a firm fixed-price, non-set-aside contract with a completion date of December 11, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999...
- The Defense Logistics Agency awarded a $2,682.39 delivery order to AmerisourceBergen Drug Corp for Exforge 10-320 mg tablets (30 count) on July 21, 2025, with completion scheduled for July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,171.24 to AmerisourceBergen Drug Corp for Exforge HCT 10-160-12.5 mg tablets (30-count supply) on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,679.83 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Exforge 5-320 mg tablets (30-count). This firm fixed-price contract, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate headquarters in...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9FK5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Exforge HCT 10-320-25 mg tablets in a 30-count package. This competitively awarded, non-set-aside contract carries a ceiling value of $1,617.29 under a firm fixed price arrangement, with an ultimate completion date of December 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and primary distribution center. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen demonstrates consistent capability in fulfilling Defense Department requirements through competitive procurement channels, with this particular order supporting the distribution of cardiovascular combination therapy medications to military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/10/25 |